نتائج البحث - "Quinson, A.-M."

1

دورية أكاديمية

137P First-in-human results from a phase I dose-escalation study of VSV-GP (BI 1831169) in patients with advanced solid tumors

المؤلفون: Champiat, S., Italiano, A., Wagle, N., Lauer, U.M., Quinson, A-M., Luecke, S., Hern, V., Porosnicu, M.

المصدر: Immuno-Oncology and Technology ; volume 20, page 100609 ; ISSN 2590-0188

مصطلحات موضوعية: Oncology, Immunology and Allergy

الإتاحة: https://doi.org/10.1016/j.iotech.2023.100609Test
https://api.elsevier.com/content/article/PII:S2590018823002721?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S2590018823002721?httpAccept=text/plainTest

View record in BASE

2

دورية أكاديمية

A phase Ib, open-label, dose-escalation trial of the anti-CD37 monoclonal antibody, BI 836826, in combination with gemcitabine and oxaliplatin in patients with relapsed/refractory diffuse large B-cell lymphoma

المؤلفون: Balzarotti M., Magagnoli M., Canales M. A., Corradini P., Grande C., Sancho J. -M., Zaja F., Quinson A. -M., Belsack V., Maier D., Carlo-Stella C.

المساهمون: M. Balzarotti, M. Magagnoli, M.A. Canale, P. Corradini, C. Grande, J.-. Sancho, F. Zaja, A.-. Quinson, V. Belsack, D. Maier, C. Carlo-Stella

مصطلحات موضوعية: BI 836826, CD37, Diffuse large B-cell lymphoma, Non-Hodgkin lymphoma, Phase I, Relapsed, Settore MED/15 - Malattie del Sangue

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33523334; info:eu-repo/semantics/altIdentifier/wos/WOS:000613600600001; numberofpages:8; journal:INVESTIGATIONAL NEW DRUGS; http://hdl.handle.net/2434/813606Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85100151200

الإتاحة: https://doi.org/10.1007/s10637-020-01054-6Test
http://hdl.handle.net/2434/813606Test

View record in BASE

3

دورية أكاديمية

Baseline Polymorphisms and Emergence of Drug Resistance in the NS3/4A Protease of Hepatitis C Virus Genotype 1 following Treatment with Faldaprevir and Pegylated Interferon Alpha 2a/Ribavirin in Phase 2 and Phase 3 Studies

المؤلفون: Berger, K. L., Scherer, J., Ranga, M., Sha, N., Stern, J. O., Quinson, A.-M., Kukolj, G.

المصدر: Antimicrobial Agents and Chemotherapy ; volume 59, issue 10, page 6017-6025 ; ISSN 0066-4804 1098-6596

الإتاحة: https://doi.org/10.1128/aac.00932-15Test

View record in BASE

4

دورية أكاديمية

Antiviral activity of low‐dose alovudine in antiretroviral‐experienced patients: results from a 4‐week randomized, double‐blind, placebo‐controlled dose‐ranging trial *

المؤلفون: Ghosn, J, Quinson, A‐M, Sabo, ND, Cotte, L, Piketty, C, Dorléacq, N, Bravo, M‐L, Mayers, D, Harmenberg, J, Mårdh, G, Valdez, H, Katlama, C

المصدر: HIV Medicine ; volume 8, issue 3, page 142-147 ; ISSN 1464-2662 1468-1293

الإتاحة: https://doi.org/10.1111/j.1468-1293.2007.00444.xTest

View record in BASE

5

دورية أكاديمية

Open-label study of faldaprevir plus peginterferon and ribavirin in hepatitis C virus genotype 1-infected patients who failed placebo plus peginterferon and ribavirin

المؤلفون: Foster, G R, Ferenci, P, Asselah, T, Mantry, P, Dufour, J-F, Bourlière, M, Forton, D, Maevskaya, M, Wright, D, Yoshida, E M, García-Samaniego, J, Oliveira, C, Wright, M, Warner, N, Sha, N, Quinson, A-M, Stern, J O

العلاقة: Foster, G R, Ferenci, P, Asselah, T, Mantry, P, Dufour, J-F, Bourlière, M, Forton, D, Maevskaya, M, Wright, D, Yoshida, E M, García-Samaniego, J, Oliveira, C, Wright, M, Warner, N, Sha, N, Quinson, A-M and Stern, J O (2016) Open-label study of faldaprevir plus peginterferon and ribavirin in hepatitis C virus genotype 1-infected patients who failed placebo plus peginterferon and ribavirin. Journal of Viral Hepatitis, 23 (3), 227-31. (doi:10.1111/jvh.12485 ).

الإتاحة: https://doi.org/10.1111/jvh.12485Test
https://eprints.soton.ac.uk/478093Test/

View record in BASE